159 results on '"Santinelli, Letizia"'
Search Results
2. Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation
3. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients
4. Chapter 11 - Interferons in human papillomavirus infection: antiviral effectors or immunopathogenic role?
5. Differential expression of Type I interferon and inflammatory genes in SARS‐CoV‐2‐infected patients treated with monoclonal antibodies
6. Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity
7. Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients
8. Unexpected increase of myocardial extracellular volume fraction in low cardiovascular risk HIV patients
9. Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
10. The Epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative Women and Men: A Ten-Year Retrospective Observational Study in Rome (Italy).
11. High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients
12. Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort
13. Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection
14. Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
15. Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women
16. Differential expression of type I interferon and inflammatory genes in SARS-CoV-2 infected patients treated with monoclonal antibodies
17. The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV
18. List of contributors
19. High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
20. Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
21. Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity
22. Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients
23. Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19
24. Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
25. The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review
26. Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial
27. Covid‐19 sequelae in working age patients: A systematic review
28. Antiretroviral Therapy Dampens Mucosal CD4+ T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1
29. Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients
30. Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
31. Viral community acquired pneumonia at the emergency department: Report from the pre COVID‐19 age
32. Preliminary attempt to predict risk of invasive pulmonary aspergillosis in patients with influenza: Decision trees may help?
33. Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
34. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
35. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection
36. Covid‐19 sequelae in working age patients: A systematic review.
37. Unexpected increase of myocardial extracellular volume fraction in low cardiovascular risk HIV patients
38. Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial
39. Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in Patients with Influenza: Decision Trees May Help?
40. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection
41. Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial
42. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
43. Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort
44. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients
45. Antiviral Activity of Fecal Water Samples from HIV-1 Infected Subjects Treated with a Specific Probiotic Formulation
46. Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study
47. Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients
48. Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS
49. Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects
50. Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.